The Mitochondrial Biology and Therapy Group investigates how mitochondrial dysfunction contributes to neurodegeneration and develops therapeutic strategies for these diseases. A major focus is the development of cell-type-targeted mitochondrial transfer therapies. To accelerate this work, we are establishing genome-wide CRISPR screening as a discovery platform to identify genes and pathways that govern donor mitochondria internalization and integration. In this role you will design, execute, and analyze pooled CRISPR knockout, activation, and interference screens to uncover novel therapeutic targets and contribute to the group's translational programs.